HELICOBACTER PYLORI INFECTION
Clinical trials for HELICOBACTER PYLORI INFECTION explained in plain language.
Never miss a new study
Get alerted when new HELICOBACTER PYLORI INFECTION trials appear
Sign up with your email to follow new studies for HELICOBACTER PYLORI INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Simpler stomach bug treatment on the horizon?
Disease control CompletedThis study tested different combinations of the acid-blocker tegoprazan with antibiotics to treat H. pylori, a common stomach infection. 640 adults who had never been treated before received one of several drug regimens for 14 days. The goal was to see which combination worked be…
Matched conditions: HELICOBACTER PYLORI INFECTION
Phase: NA • Sponsor: Zhongshan Hospital (Xiamen), Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New antibiotic mix aims to tame tough stomach bug with fewer side effects
Disease control CompletedThis study tested different doses of the antibiotics minocycline and metronidazole, combined with bismuth and a stomach acid blocker, to treat Helicobacter pylori infections that didn't clear with previous treatments. 480 adults who had failed earlier therapy were randomly assign…
Matched conditions: HELICOBACTER PYLORI INFECTION
Phase: PHASE4 • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New stomach bug treatment showdown: which works better?
Disease control CompletedThis study tested two different drug combinations to treat Helicobacter pylori, a stomach infection that can cause ulcers. About 400 adults took either a two-drug regimen (tegoprazan and amoxicillin) or a four-drug regimen (including bismuth and furazolidone). The goal was to see…
Matched conditions: HELICOBACTER PYLORI INFECTION
Phase: NA • Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New dual therapy may simplify h. pylori treatment without losing effectiveness
Disease control CompletedThis study tested whether a two-drug combination (vonoprazan plus either amoxicillin or doxycycline) works as well as the standard four-drug bismuth quadruple therapy for eradicating H. pylori infection. 579 adults with H. pylori took one of three 14-day treatments. Researchers m…
Matched conditions: HELICOBACTER PYLORI INFECTION
Phase: NA • Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New Two-Drug combo could simplify h. pylori treatment
Disease control CompletedThis study tested a 14-day treatment using two drugs (vonoprazan and amoxicillin) against a more complex seven-then-seven-day regimen for H. pylori infection in 337 adults in Taiwan. The goal was to see if the simpler dual therapy works just as well, with fewer side effects and e…
Matched conditions: HELICOBACTER PYLORI INFECTION
Phase: PHASE4 • Sponsor: Fu Jen Catholic University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Herbal combo boosts h. pylori treatment, study finds
Disease control CompletedThis study tested whether adding a traditional Chinese herbal formula (Banxiaxiexin decoction) to standard antibiotics can better treat H. pylori infection and related indigestion. 104 adults with both conditions took either the herbal combo or standard therapy for 14 days. The m…
Matched conditions: HELICOBACTER PYLORI INFECTION
Phase: PHASE3 • Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New two-drug combo may beat standard four-drug therapy for stomach bug
Disease control CompletedThis study tested whether a simpler two-drug treatment (tegoprazan and amoxicillin) works better than the standard four-drug therapy for eradicating H. pylori, a bacteria that can cause stomach ulcers. 370 adults with H. pylori infection were randomly assigned to one of the two t…
Matched conditions: HELICOBACTER PYLORI INFECTION
Phase: PHASE4 • Sponsor: Zhang Xiaofeng,MD • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Which works better for h. pylori? triple vs quadruple therapy showdown
Disease control CompletedThis study tested two different 14-day drug combinations to treat Helicobacter pylori, a bacteria that causes stomach inflammation and ulcers. Over 750 adults were randomly assigned to either a triple therapy (omeprazole, amoxicillin, clarithromycin) or a quadruple therapy (omepr…
Matched conditions: HELICOBACTER PYLORI INFECTION
Phase: PHASE4 • Sponsor: Azfar Farogh • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New drug combo aims to knock out stomach bug in phase 3 trial
Disease control CompletedThis study tested whether a new triple therapy containing DWP14012 is as good as the standard treatment for eradicating H. pylori, a bacteria that can cause stomach ulcers. 461 adults with confirmed H. pylori infection took part. The main goal was to see if the infection was gone…
Matched conditions: HELICOBACTER PYLORI INFECTION
Phase: PHASE3 • Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Battle of the bacteria: which drug combo wins against resistant h. pylori?
Disease control CompletedThis study tested two different drug combinations in 782 people with H. pylori infection that was resistant to the antibiotic clarithromycin. One group received a triple therapy with a proton pump inhibitor, amoxicillin, and metronidazole, while the other received a quadruple the…
Matched conditions: HELICOBACTER PYLORI INFECTION
Phase: NA • Sponsor: Kangdong Sacred Heart Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New triple therapy may finally knock out tough stomach bug
Disease control CompletedThis study tested whether a three-drug combination containing rifabutin can wipe out Helicobacter pylori infections that didn't respond to earlier treatments. 360 adults who had failed prior therapy were randomly assigned to one of three regimens. The goal was to see which approa…
Matched conditions: HELICOBACTER PYLORI INFECTION
Phase: PHASE4 • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 26, 2026 17:06 UTC
-
Can a closer look at the stomach spot hidden infections?
Diagnosis CompletedThis trial compares two endoscopic techniques—standard white light endoscopy and magnifying endoscopy with narrow-band imaging—to see which better identifies the status of Helicobacter pylori (Hp) infection. About 384 participants will undergo both procedures, and the accuracy of…
Matched conditions: HELICOBACTER PYLORI INFECTION
Sponsor: Jilin University • Aim: Diagnosis
Last updated Aug 08, 2026 00:03 UTC
-
Scientists map gut bugs in double infection
Knowledge-focused CompletedThis study looked at 42 adults with both H. pylori infection and small intestinal bacterial overgrowth (SIBO). Researchers used advanced DNA and chemical tests on stool samples to map the types of gut bacteria and their byproducts. The goal was to better understand how these two …
Matched conditions: HELICOBACTER PYLORI INFECTION
Sponsor: Zhongshan Hospital (Xiamen), Fudan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Stomach bug treatment may alter vaginal health, study finds
Knowledge-focused CompletedThis study looked at whether antibiotics for H. pylori (a stomach infection) change the natural bacteria in the vagina. Researchers followed 73 women getting treatment and 10 healthy women. They collected vaginal samples before and after treatment to see if the bacteria mix shift…
Matched conditions: HELICOBACTER PYLORI INFECTION
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
New drug interaction study completed in healthy and infected volunteers
Knowledge-focused CompletedThis study looked at how a new drug called linaprazan glurate interacts with common antibiotics (clarithromycin, amoxicillin) and bismuth in 56 adults. Some participants were healthy and H. pylori-negative, while others had H. pylori infection. The goal was to measure drug levels…
Matched conditions: HELICOBACTER PYLORI INFECTION
Phase: PHASE1 • Sponsor: Jiangsu Sinorda Biomedicine Co., Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Bismuth combo therapy for stomach bug under review
Knowledge-focused CompletedThis study looked back at medical records of 1,730 adults with H. pylori infection who received bismuth-containing quadruple therapy as their first treatment. Researchers compared how well different drug combinations worked and what side effects occurred. The goal was to identify…
Matched conditions: HELICOBACTER PYLORI INFECTION
Sponsor: Yueyue Li • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:22 UTC